---
figid: PMC3069685__oncotarget-01-457-g002
figlink: /pmc/articles/PMC3069685/figure/F2/
number: Figure 2
caption: Cell surface receptors (FGFR or EGFR) activate RAS/MAPK or PI3K signaling
  pathways through FGFR substrate 2 (FRS2) and culminate in the activation of CREB3L2,
  which in turn stimulates transcription of ATF5. ATF5 then antagonizes apoptosis
  by directly up-regulating expression of the anti-apoptotic factor MCL1. Commercially
  available pharmacological inhibitors of several components of the ATF5-mediated
  survival pathway are indicated in gray.
pmcid: PMC3069685
papertitle: An Activating Transcription Factor 5-Mediated Survival Pathway as a Target
  for Cancer Therapy.
reftext: Zhi Sheng, et al. Oncotarget. 2010 Oct;1(6):457-460.
pmc_ranked_result_index: '6925'
pathway_score: 0.9519178
filename: oncotarget-01-457-g002.jpg
figtitle: An Activating Transcription Factor 5-Mediated Survival Pathway as a Target
  for Cancer Therapy
year: '2010'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3069685__oncotarget-01-457-g002.html
  '@type': Dataset
  description: Cell surface receptors (FGFR or EGFR) activate RAS/MAPK or PI3K signaling
    pathways through FGFR substrate 2 (FRS2) and culminate in the activation of CREB3L2,
    which in turn stimulates transcription of ATF5. ATF5 then antagonizes apoptosis
    by directly up-regulating expression of the anti-apoptotic factor MCL1. Commercially
    available pharmacological inhibitors of several components of the ATF5-mediated
    survival pathway are indicated in gray.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R6
  - MAP2K2
  - PIK3CG
  - PAK1
  - NRAS
  - HRAS
  - MAP2K1
  - PIK3R5
  - KRAS
  - BRAF
  - PIK3CD
  - PIK3R3
  - ATF5
  - RAF1
  - FRS2
  - MCL1
  - AKT2
  - CREB3L2
  - PIK3CA
  - PIK3CB
  - AKT1
  - ARAF
  - MAPK3
  - AKT3
  - PIK3R4
  - MAPK1
  - Manumycin A
  - LY294002
  - U0126H
  - PD173074
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PAK1
  symbol: PAK1
  source: hgnc_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: ATF5
  symbol: ATF5
  source: hgnc_symbol
  hgnc_symbol: ATF5
  entrez: '22809'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: FRS2
  symbol: FRS2
  source: hgnc_symbol
  hgnc_symbol: FRS2
  entrez: '10818'
- word: MCL1
  symbol: MCL1
  source: hgnc_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CREB3L2
  symbol: CREB3L2
  source: hgnc_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: Manumycin A
  source: MESH
  identifier: C054474
- word: LY294002
  source: MESH
  identifier: C085911
- word: U0126H
  source: MESH
  identifier: C113580
- word: PD173074
  source: MESH
  identifier: C115711
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
